Literature DB >> 2877889

Opposing effects of D-1 and D-2 receptor antagonists on acetylcholine levels in the rat striatum.

D Fage, B Scatton.   

Abstract

In contrast to D-2 or mixed D-1/D-2 receptor antagonists which decrease rat striatal acetylcholine levels, the D-1 receptor antagonist SCH 23390 increased this biochemical parameter (ED50 = 0.04 mg/kg s.c.) suggesting a reduction of acetylcholine turnover. SCH 23390 blocked the ability of haloperidol or sulpiride to diminish striatal acetylcholine levels and potentiated the increase in this biochemical parameter induced by the selective D-2 receptor agonist LY 141865. These findings indicate that blockade of D-1 and D-2 receptors causes opposite actions on striatal cholinergic neurons.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2877889     DOI: 10.1016/0014-2999(86)90447-4

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  11 in total

1.  The effect of intrastriatal application of directly and indirectly acting dopamine agonists and antagonists on the in vivo release of acetylcholine measured by brain microdialysis. The importance of the post-surgery interval.

Authors:  P De Boer; G Damsma; Q Schram; J C Stoof; J Zaagsma; B H Westerink
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-02       Impact factor: 3.000

2.  Activation of dopamine D1 receptors does not affect D2 receptor-mediated inhibition of acetylcholine release in rabbit striatum.

Authors:  V Dolezal; R Jackisch; G Hertting; C Allgaier
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-01       Impact factor: 3.000

3.  Effects of acute and subacute cocaine administration on the CNS dopaminergic system in Wistar-Kyoto and spontaneously hypertensive rats: II. Dopamine receptors.

Authors:  D K Lim; Z J Yu; B Hoskins; R W Rockhold; I K Ho
Journal:  Neurochem Res       Date:  1990-06       Impact factor: 3.996

4.  Effect of the D1 receptor agonist SKF 38393 on some behavioural effects of apomorphine in rats.

Authors:  A M Zarkovsky; K S Cereska
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-04       Impact factor: 3.000

Review 5.  The motor effects of bromocriptine--a review.

Authors:  D M Jackson; O F Jenkins; S B Ross
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

6.  Chronic treatment with D1 and D2 dopamine receptor agonists: combined treatments interact to differentially affect brain levels of monoamines.

Authors:  M T Martin-Iverson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-09       Impact factor: 3.000

7.  Drugs acting at D-1 and D-2 dopamine receptors induce identical purposeless chewing in rats which can be differentiated by cholinergic manipulation.

Authors:  P Collins; C L Broekkamp; P Jenner; C D Marsden
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

8.  Alterations in striatal acetylcholine overflow by cocaine, morphine, and MK-801: relationship to locomotor output.

Authors:  A Zocchi; A Pert
Journal:  Psychopharmacology (Berl)       Date:  1994-07       Impact factor: 4.530

9.  Interactions of drugs acting on central dopamine receptors and cholinoceptors on yawning responses in the rat induced by apomorphine, bromocriptine or physostigmine.

Authors:  M R Zarrindast; M Poursoltan
Journal:  Br J Pharmacol       Date:  1989-04       Impact factor: 8.739

10.  Further studies on the interaction between bromocriptine and SKF38393 in reserpine and alpha methyl-para-tyrosine-treated mice.

Authors:  D M Jackson; S B Ross; M Hashizume
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.